A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase

被引:287
|
作者
Meyer, PR
Matsuura, SE
Mian, AM
So, AG
Scott, WA [1 ]
机构
[1] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
[2] Univ Miami, Sch Med, Dept Med, Miami, FL 33101 USA
关键词
D O I
10.1016/S1097-2765(00)80185-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in HIV-1 reverse transcriptase (RT) give rise to 3'-azido-3'-deoxythymidine (AZT) resistance by a mechanism that has not been previously reproduced in vitro. We show that mutant RT has increased ability to remove AZTMP from blocked primers through a nucleotide-dependent reaction, producing dinucleoside polyphosphate and extendible primer. In the presence of physiological concentrations of ATP, mutant RT extended 12% to 15% of primers past multiple AZTMP termination sites versus less than 0.5% for wild type. Although mutant RT also unblocked ddAMP-terminated primers more efficiently than wild-type RT, the removal of ddAMP was effectively inhibited by the next complementary dNTP (ICS50 approximate to 12 mu M). In contrast, the removal of AZTMP was not inhibited by dNTPs except at nonphysiological concentrations (ICS50 > 200 mu M).
引用
收藏
页码:35 / 43
页数:9
相关论文
共 50 条
  • [41] Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template
    Canard, B
    Sarfati, R
    Richardson, CC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11279 - 11284
  • [42] Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis
    Ray, AS
    Murakami, E
    Basavapathruni, A
    Vaccaro, JA
    Ulrich, D
    Chu, CK
    Schinazi, RF
    Anderson, KS
    BIOCHEMISTRY, 2003, 42 (29) : 8831 - 8841
  • [43] Molecular Origins of HIV-1 reverse Transcriptase Resistance to Efavirenz
    Deredge, Daniel J.
    Howard, Kathryn J.
    Seckler, James M.
    Barkley, Mary D.
    Wintrode, Patrick L.
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 227 - 227
  • [44] DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge
    Isaguliants, MG
    Petrakova, N
    Zuber, B
    Pokrovskaya, K
    Gizatullin, R
    Kostyuk, DA
    Kjerrström, A
    Winberg, G
    Kochetkov, SN
    Hinkula, J
    Wahren, B
    INTERVIROLOGY, 2000, 43 (4-6) : 288 - 293
  • [45] Nucleotide substitution pattern can predict the requirements for drug resistance of the HIV-1 reverse transcriptase protein
    Keulen, W
    Boucher, C
    Berkhout, B
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 8 - 8
  • [46] Nonnucleoside Reverse Transcriptase Inhibitor Hypersusceptibility and Resistance by Mutation of Residue 181 in HIV-1 Reverse Transcriptase
    Barnard, John P.
    Huber, Kelly D.
    Sluis-Cremer, Nicolas
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [47] Understanding the molecular mechanism of sequence dependent Tenofovir removal by HIV-1 reverse transcriptase: Differences in primer binding site versus polypurine tract
    Iyidogan, Pinar
    Anderson, Karen S.
    ANTIVIRAL RESEARCH, 2012, 95 (02) : 93 - 103
  • [48] Genetic diversity and complexity of drug resistance continue to increase in the reverse transcriptase and protease regions of HIV-1
    van Vlijmen, H.
    Van Houtte, M.
    Van der Borght, K.
    Lecocq, P.
    Bacheler, L.
    Sista, P.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A82 - A82
  • [49] Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase
    Tong, WJ
    Lu, CD
    Sharma, SK
    Matsuura, S
    So, AG
    Scott, WA
    BIOCHEMISTRY, 1997, 36 (19) : 5749 - 5757
  • [50] Characterization of HIV-1 Reverse Transcriptase Nucleotide Specificity by Conformationally Sensitive Fluorescence
    Kellinger, Matthew William
    Piasecki, Shawn
    Johnson, Kenneth Allen
    FASEB JOURNAL, 2009, 23